Companies To Watch

  1. Companies To Watch: Terns Pharmaceuticals 11/26/2024

    Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small molecules.

  2. Companies To Watch: Spinogenix 10/18/2024

    Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, glaucoma, and Fragile X syndrome.

  3. Companies To Watch: Aurion Biotech 8/30/2024

    Aurion Biotech is developing what could become the first allogeneic combination cell therapy for the treatment of corneal endothelial diseases.

  4. Companies To Watch: Athira Pharma 7/16/2024

    Athira Pharma is developing small molecule therapeutics for neurodegenerative diseases, including its lead candidate, fosgonimeton, for Alzheimer's disease.

  5. Companies To Watch: Volastra Therapeutics 6/26/2024

    Volastra Therapeutics is a drug discovery and development leader in the emerging field of chromosomal instability, a phenomenon that can determine how certain solid tumor cancer cells replicate and grow.

  6. Companies To Watch: OSE Immunotherapeutics 4/22/2024

    OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.

  7. Companies To Watch: Antiva Biosciences 2/27/2024

    Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.

  8. Companies to Watch: Promontory Therapeutics 2/1/2024

    A novel small molecule developer aims to shake up the solid tumor treatment landscape.

  9. Companies To Watch: KeifeRx 1/1/2024

    Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.

  10. Companies To Watch: Freya Biosciences 11/1/2023

    Freya Biosciences is enlivening the long-time lonely space of reproductive health, starting with a new focus on the vaginal microbiome.